In line with earlier studies showing that circulating FABP4 is closely associated with obesity and metabolic syndrome [9, 18, 19], this finding highlights the significant role of macrophage in releasing FABP4 among the BMI-selected cohort. Here, FABP4 is linked to obesity disorder.